Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels


Synlogic Announces That It Has Initiates Its Phase 1 Study Of The SYNB8802 For The Treatment Of Enteric Hyperoxaluria


Benzinga | Nov 4, 2020 04:28PM EST

Synlogic Announces That It Has Initiates Its Phase 1 Study Of The SYNB8802 For The Treatment Of Enteric Hyperoxaluria






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC